Eva V. E. Madsen

1.6k total citations
49 papers, 488 citations indexed

About

Eva V. E. Madsen is a scholar working on Surgery, Emergency Medicine and Reproductive Medicine. According to data from OpenAlex, Eva V. E. Madsen has authored 49 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 20 papers in Emergency Medicine and 11 papers in Reproductive Medicine. Recurrent topics in Eva V. E. Madsen's work include Intraperitoneal and Appendiceal Malignancies (31 papers), Appendicitis Diagnosis and Management (20 papers) and Breast Lesions and Carcinomas (10 papers). Eva V. E. Madsen is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (31 papers), Appendicitis Diagnosis and Management (20 papers) and Breast Lesions and Carcinomas (10 papers). Eva V. E. Madsen collaborates with scholars based in Netherlands, United States and Belgium. Eva V. E. Madsen's co-authors include Cornelis Verhoef, Jacobus W. A. Burger, Thijs van Dalen, Nadine L. de Boer, Paul D. Gobardhan, Alexandra R. M. Brandt‐Kerkhof, Vivian Bongers, Joost van Gorp, Joachim G.J.V. Aerts and Inne H.M. Borel Rinkes and has published in prestigious journals such as Gastroenterology, Annals of Oncology and Thorax.

In The Last Decade

Eva V. E. Madsen

44 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva V. E. Madsen Netherlands	14	284	178	142	139	112	49	488
Robert Bachmann Germany	11	169 0.6×	100 0.6×	14 0.1×	195 1.4×	99 0.9×	36	424
Isabelle Sourrouille France	9	216 0.8×	64 0.4×	105 0.7×	244 1.8×	119 1.1×	30	412
Valerio Sciascia Italy	8	244 0.9×	131 0.7×	90 0.6×	125 0.9×	62 0.6×	16	357
Wilson Toshihiko Nakagawa Brazil	13	231 0.8×	89 0.5×	169 1.2×	336 2.4×	82 0.7×	40	478
Wen‐Yih Liang Taiwan	10	153 0.5×	29 0.2×	103 0.7×	202 1.5×	80 0.7×	17	353
Taro Tanabe Japan	12	137 0.5×	51 0.3×	117 0.8×	312 2.2×	120 1.1×	25	478
Stylianos Giassas Greece	8	318 1.1×	41 0.2×	14 0.1×	158 1.1×	121 1.1×	20	493
Č Neoral Czechia	11	363 1.3×	61 0.3×	45 0.3×	200 1.4×	304 2.7×	118	590
Jae Huh United States	11	852 3.0×	54 0.3×	44 0.3×	152 1.1×	152 1.4×	14	1.2k
François-Noël Gilly France	12	171 0.6×	14 0.1×	28 0.2×	96 0.7×	197 1.8×	20	373

Countries citing papers authored by Eva V. E. Madsen

Since Specialization

Citations

This map shows the geographic impact of Eva V. E. Madsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva V. E. Madsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva V. E. Madsen more than expected).

Fields of papers citing papers by Eva V. E. Madsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva V. E. Madsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva V. E. Madsen. The network helps show where Eva V. E. Madsen may publish in the future.

Co-authorship network of co-authors of Eva V. E. Madsen

This figure shows the co-authorship network connecting the top 25 collaborators of Eva V. E. Madsen. A scholar is included among the top collaborators of Eva V. E. Madsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva V. E. Madsen. Eva V. E. Madsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erning, Felice N. van, Patrick Hemmer, Eva V. E. Madsen, et al.. (2025). Recurrence patterns following CRS-HIPEC in patients with colorectal peritoneal metastases: Insights from the Dutch CRS-HIPEC registry. European Journal of Surgical Oncology. 51(12). 110501–110501.

Hannink, Gerjon, Alexandra R. M. Brandt‐Kerkhof, Cornelis Verhoef, et al.. (2024). Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. European Journal of Surgical Oncology. 50(6). 108294–108294. 1 indexed citations

Popuri, Karteek, Da Ma, Vincent Chow, et al.. (2024). Evaluation of a fully automated computed tomography image segmentation method for fast and accurate body composition measurements. Nutrition. 129. 112592–112592. 3 indexed citations

Sijtsma, F.P.C., Alexandra R. M. Brandt‐Kerkhof, André J. A. Bremers, et al.. (2024). An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry. European Journal of Surgical Oncology. 50(12). 108568–108568. 1 indexed citations

Lurvink, Robin J., Esther van Meerten, Geert-Jan Creemers, et al.. (2024). Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial. BMJ Open. 14(1). e077667–e077667. 2 indexed citations

Tanis, Pieter J., Ron H.J. Mathijssen, Irene E.G. van Hellemond, et al.. (2024). Neoadjuvant intraperitoneal chemotherapy combined with systemic therapy prior to CRS-HIPEC for patients with resectable colorectal peritoneal metastases: Protocol of the phase II, INTERACT-PLUS trial. European Journal of Surgical Oncology. 50. 108802–108802. 1 indexed citations

Quintelier, Katrien, Nadine L. de Boer, Alexandra R. M. Brandt‐Kerkhof, et al.. (2023). Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial. Journal for ImmunoTherapy of Cancer. 11(8). e007070–e007070. 9 indexed citations

Paats, Marthe S., et al.. (2023). Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies. ESMO Open. 8(4). 101600–101600. 8 indexed citations

Noordman, Bo Jan, Stijn L.W. Koolen, Bianca Mostert, et al.. (2023). Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies. Drugs. 83(2). 159–180. 22 indexed citations

10.

Brandt‐Kerkhof, Alexandra R. M., Stijn L.W. Koolen, Jacobus W. A. Burger, et al.. (2022). Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study—INTERACT MESO. BMJ Open. 12(6). e062907–e062907. 3 indexed citations

11.

Belderbos, Robert A., Jan H. von der Thüsen, Mieke J. Aarts, et al.. (2022). Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study. Thorax. 77(12). 1260–1267. 24 indexed citations

12.

Brandt‐Kerkhof, Alexandra R. M., et al.. (2022). Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study. Annals of Surgical Oncology. 30(4). 2048–2056.

13.

Brandt‐Kerkhof, Alexandra R. M., Cornelis Verhoef, Andreas J. A. Bremers, et al.. (2022). Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma. Annals of Surgical Oncology. 29(11). 6566–6576. 11 indexed citations

14.

Boer, Nadine L. de, et al.. (2019). Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study. Annals of Surgical Oncology. 26(13). 4222–4228. 19 indexed citations

15.

Boer, Nadine L. de, Alexandra R. M. Brandt‐Kerkhof, Eva V. E. Madsen, et al.. (2019). Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial. BMJ Open. 9(12). e034508–e034508. 17 indexed citations

16.

Gobardhan, Paul D., et al.. (2011). Ultrasound-guided sentinel node procedure for nonpalpable breast carcinoma. Nuclear Medicine Communications. 33(1). 80–83. 1 indexed citations

17.

Gobardhan, Paul D., Eva V. E. Madsen, E. Theunissen, et al.. (2010). Prognostic Value of Lymph Node Micrometastases in Breast Cancer: A Multicenter Cohort Study. Annals of Surgical Oncology. 18(6). 1657–1664. 42 indexed citations

18.

Gobardhan, Paul D., et al.. (2010). Discordance of Intraoperative Frozen Section Analysis with Definitive Histology of Sentinel Lymph Nodes in Breast Cancer Surgery: Complementary Axillary Lymph Node Dissection is Irrelevant for Subsequent Systemic Therapy. Annals of Surgical Oncology. 17(10). 2690–2695. 20 indexed citations

19.

Madsen, Eva V. E., Jan van Dalen, Joost van Gorp, Inne H.M. Borel Rinkes, & Thijs van Dalen. (2008). Strategies for optimizing pathologic staging of sentinel lymph nodes in breast cancer patients. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 453(1). 17–24. 12 indexed citations

20.

Gobardhan, Paul D., et al.. (2008). Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study. Annals of Oncology. 20(1). 41–48. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact